← Leaderboards
Donald E Craven
Boston University Medical Campus
$1,143,427
Attributed
$1,143,427
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,143,427 · 3
By mechanism
R01$1,112,940 · 1
M01$30,487 · 2
Top collaborators
No co-investigators on record.
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Michael D Stein$43,083,732
- Thomas William Geisbert$89,759,942
- Paul F Pilch$12,079,735
- Jeffrey H Samet$129,777,857
- Robert Christopher Pierce$18,763,925
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchHiv InfectionsHuman Therapy EvaluationAntiaids AgentVirus ReplicationAntiviral AgentsCellular ImmunityComorbidityHelper T LymphocyteHepatitis CImmunosuppressionPathologic ProcessPrognosisSubstance Abuse EpidemiologySubstance Abuse Related BehaviorVirus LoadAids TherapyDrug Related Diabetes MellitusLongitudinal Human StudyProtease InhibitorDrug Adverse EffectClinical ChemistryAids
Grant awards (6)
NATURAL HISTORY OF HEPATITIS C INFECTION IN HIV DISEASE$523,520
R01 · FY2001 · DK
WF10 (TCD) INTRAVENOUS SOLUTION IN MANAGEMENT OF PATIENTS WITH HIV DISEASE$0
M01 · FY2001 · RR
NATURAL HISTORY OF HEPATITIS C INFECTION IN HIV DISEASE$514,420
R01 · FY2000 · DK
NATURAL HISTORY OF HEPATITIS C INFECTION IN HIV DISEASE$75,000
R01 · FY2000 · DK
HIV INF PATIENTS RECEIVING PROTEASE INHIBITORS WHO DEVELOPED DIABETES$30,487
M01 · FY2000 · RR
WF10 (TCD) INTRAVENOUS SOLUTION IN MANAGEMENT OF PATIENTS WITH HIV DISEASE$0
M01 · FY2000 · RR